Ultralife Q4 Adj. EPS $0.18 Beats $0.09 Estimate, Sales $44.55M Beat $39.00M Estimate
Portfolio Pulse from Benzinga Newsdesk
Ultralife Corporation (NASDAQ:ULBI) reported Q4 adjusted earnings of $0.18 per share, surpassing the $0.09 estimate, marking a significant turnaround from last year's losses. Sales reached $44.55M, exceeding the $39.00M forecast and showing a 23.38% year-over-year increase.
February 15, 2024 | 12:03 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Ultralife Corporation reported a significant beat on both earnings and sales estimates for Q4, showcasing strong financial performance and growth.
Ultralife's substantial beat on both earnings per share and sales estimates, coupled with a significant year-over-year growth, indicates a strong financial performance. This is likely to positively influence investor sentiment and potentially lead to a short-term increase in stock price.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100